The management of patients with an intrinsic supratentorial brain tumour

British Journal of Neurosurgery

Volumn 4, Issue 4, 1990, Pages 299-312

  Sandeman, David R ^b   Sandeman, Alison P ^c   Buxton, Peter ^a   Hughes, Hugh H ^d   Chadwick, David W ^a   Williams, Ian R ^a   Baker, Rose D ^e   Foy, Patrick M ^a   Shaw, M Donald M ^a  

^a WALTON HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c Royal Liverpool Infirmary   (United Kingdom)

^d CLATTERBRIDGE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF SALFORD   (United Kingdom)

Author keywords

Astrocytoma; Brain tumour; Malignant glioma; Radiation therapy; Steroids; Surgery

Indexed keywords

CORTICOSTEROID;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CHILD; FATALITY; FEMALE; GLIOBLASTOMA; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BIOPSY; BRAIN; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; CRANIOTOMY; DATABASES, BIBLIOGRAPHIC; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMAN; MALE; MIDDLE AGE; PROGNOSIS; RETROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS; SURVIVAL RATE;

EID: 0025102238     PISSN: 02688697     EISSN: None     Source Type: Journal    
DOI: 10.3109/02688699008992739     Document Type: Article

References (23)

1. Discussion on current trends in the management of the glomata
2. Chemotherapy of malignant gliomas
3. Differences between neurological and neurosurgical approaches in the management of malignant brain turnours
4. How to treat glioblastomas
5. Nonparametric estimation from incomplete observations
6. Survival in glioblastoma: Historical perspective
7. Comparisons of carmustine, procarbazine, and high-dose methylpred-nisolone as additions to surgery and radiotherapy for the treatment of malignant glioma
8. Randomised phase II comparison of PCNU and AZQ for the treatment of primary brain turnours
9. Evaluation of CC.N.U., VM-26 plus CCNU and Procarbazine in supratentorial brain gliomas Final evaluation of a randomised study
10. Misonidazole in radiotherapy of supratentorial malignant brain gliomas: randomised double-blind study
11. Misonidazole combined with hyperfractionation in the management of malignant gliomata
12. Chemotherapy of malignant gliomas
13. Assay of anti-cancer drugs in tissue culture: relationship of relapse free interval (RFI) and in vino chemosensitiv-ity in patients with malignant cerebral glioma
14. The effect of age and reoperation on survival in the combined modality treatment of malignant astrocytoma
15. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial
16. Combined treatment of malignant gliomas
17. Radiation therapy for neoplasms of the brain
18. High dose radiation therapy in the treatment of malignant gliomas: final report
19. An analysis of dose effect relationship in the radiotherapy of malignant gliomas
20. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multi-disciplinary management of malignant gliomas. A Joint Radiation Therapy Oncology and Eastern Cooperative Oncology Group Study